Zkusit zdarma
Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

SGMO
Cena:
 
 
Valuace
70
Růst
53
Zdraví
75
preloader

Finanční výsledky Sangamo Therapeutics, Inc. (SGMO)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-0.44-0.49-1.48-1.25-1.23
Gross Profit39.6M57.8M176.2M111.3M110.7M
Net Income Attributable to Common Shareholders-122.9M-97.9M-257.8M-192.3M-178.3M
Operating Profit-121.2M-104M-274M-201.3M-183.3M
Total Revenues39.6M57.8M176.2M111.3M110.7M